POTASSIUM CHLORIDE 20 mmol in SODIUM CHLORIDE 0.9% 1000 mL injection for intravenous infusion bottle Australia - engelsk - Department of Health (Therapeutic Goods Administration)

potassium chloride 20 mmol in sodium chloride 0.9% 1000 ml injection for intravenous infusion bottle

fresenius kabi australia pty ltd - sodium chloride, quantity: 9 g/l; potassium chloride, quantity: 1.5 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; hydrochloric acid - a source of water and to restore electrolyte balance as required by a patient's clinical condition, such as hypokalaemia

POTASSIUM CHLORIDE 40 mmol in SODIUM CHLORIDE 0.9% 1000 mL injection for intravenous infusion bottle Australia - engelsk - Department of Health (Therapeutic Goods Administration)

potassium chloride 40 mmol in sodium chloride 0.9% 1000 ml injection for intravenous infusion bottle

fresenius kabi australia pty ltd - potassium chloride, quantity: 3 g/l; sodium chloride, quantity: 9 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; hydrochloric acid - a source of water and to restore electrolyte balance as required by a patient's clinical condition, such as hypokalaemia

MANNITOL IV INFUSION Kenya - engelsk - Pharmacy and Poisons Board

mannitol iv infusion

amanta healthcare limited c/o surgilinks ltd plot no. 876 national highway no. 8 hariyana- - mannitol intravenous infusion bp - infusion - 20gm/100ml - intravenous solutions: solutions producing

Mannitol 75g/500ml (15%) infusion Viaflo bags Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

mannitol 75g/500ml (15%) infusion viaflo bags

15%) infusion viaflo bags (baxter healthcare ltd - mannitol - infusion - 150mg/1ml

MANNITOL injection, solution USA - engelsk - NLM (National Library of Medicine)

mannitol injection, solution

hospira, inc. - mannitol (unii: 3owl53l36a) (mannitol - unii:3owl53l36a) - mannitol 5 g in 100 ml - mannitol injection is indicated for the reduction of: - intracranial pressure and treatment of cerebral edema. - elevated intraocular pressure. mannitol injection is contraindicated in patients with: - known hypersensitivity to mannitol [see warnings and precautions (5.1)]. - anuria [see warnings and precautions (5.2)]. - severe hypovolemia [see warnings and precautions (5.4)]. - pre-existing severe pulmonary vascular congestion or pulmonary edema [see warnings and precautions (5.5)] . - active intracranial bleeding except during craniotomy. risk summary the available case report data with mannitol over decades of use have not identified a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. mannitol crosses the placenta and may cause fluid shifts that could potentially result in adverse effects in the fetus (see data) .no adverse developmental effects from mannitol were reported in published animal studies; however, fluid shifts occurred in fetal ewes in resp

MANNITOL injection, solution USA - engelsk - NLM (National Library of Medicine)

mannitol injection, solution

general injectables & vaccines, inc - mannitol (unii: 3owl53l36a) (mannitol - unii:3owl53l36a) - mannitol 250 mg in 1 ml - mannitol injection is indicated for the reduction of: - intracranial pressure and treatment of cerebral edema. - elevated intraocular pressure. mannitol injection is contraindicated in patients with: - known hypersensitivity to mannitol [see warnings and precautions (5.1)]. - anuria [see warnings and precautions (5.2)]. - severe hypovolemia [see warnings and precautions (5.4)]. - pre-existing severe pulmonary vascular congestion or pulmonary edema [see warnings and precautions (5.5)]. - active intracranial bleeding except during craniotomy. 8.1 pregnancy risk summary the available case report data with mannitol over decades of use have not identified a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. mannitol crosses the placenta and may cause fluid shifts that could potentially result in adverse effects in the fetus (see data).no adverse developmental effects from mannitol were reported in published animal studies; however, fluid shifts occurred in fetal ewes i

BAXTER POTASSIUM CHLORIDE 40 mmol and 0.9% SODIUM CHLORIDE 1000 mL intravenous infusion bag Australia - engelsk - Department of Health (Therapeutic Goods Administration)

baxter potassium chloride 40 mmol and 0.9% sodium chloride 1000 ml intravenous infusion bag

baxter healthcare pty ltd - potassium chloride, quantity: 2.98 g/l; sodium chloride, quantity: 9 g/l - injection, intravenous infusion - excipient ingredients: water for injections; hydrochloric acid - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.

Mannitol 50g/250ml (20%) infusion Viaflex bags Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

mannitol 50g/250ml (20%) infusion viaflex bags

20%) infusion viaflex bags (baxter healthcare ltd - mannitol - infusion - 200mg/1ml

NIMODIPINE JUNO nimodipine 10 mg/50 mL concentrated intravenous infusion solution vial Australia - engelsk - Department of Health (Therapeutic Goods Administration)

nimodipine juno nimodipine 10 mg/50 ml concentrated intravenous infusion solution vial

juno pharmaceuticals pty ltd - nimodipine, quantity: 10 mg - injection, intravenous infusion - excipient ingredients: citric acid; sodium citrate dihydrate; water for injections; ethanol; macrogol 400 - prophylaxis and treatment of ischaemic neurological deficits caused by cerebral vasospasm after subarachnoid haemorrhage following ruptured intracranial aneurysm, in patients who are in good neurological condition post-ictus, e.g., hunt and hess grades i-iii (see section 5.1 pharmacodynamic properties).

Mannitol 20% Malta - engelsk - Medicines Authority

mannitol 20%

demo s.a. pharmaceutical industry 21st km national road athens - lamia 14568 krioneri, greece - mannitol - solution for infusion - mannitol 200 mg/l - blood substitutes and perfusion solutions